miDIAGNOSTICS news

In the past year miDiagnostics has been working on the development of an ultra-fast PCR test based on imec technology, to detect COVID-19, with a test result in less than 15 minutes. In cooperation with Brussels Airport, this nasal-swab ultra-fast PCR test, as well as the new breath sampler developed by imec and licensed by miDiagnostics, will be tested in practice during a study at the airport’s Test Centre. Imec was able to develop the technology thanks to the support of the F

25 European companies from the Biotech, Medtech, Innovative Services & Digital Health sectors, committed to patients, selected by the European clusters, will present their innovation to a jury composed of HTFC’s sponsors and the HTID health innovation ecosystem.

The HealthTech Innovation Days (HTID®) event, organized by the HealthTech For Care (HTFC) endowment fund, is launching for the first time a pitch competition for European healthcare companies committed to

The COVID-19, pandemic amongst other changes in our lifestyle, has introduced us to new medical terms that we are not quite familiar with, such as the term PCR (polymerase chain reaction). As you may already know, PCR is a method to detect SARS-COV-2 virus, more specifically its nucleic acid. It is the “golden standard” of SARS-2 detection, as declared by the World Health Association (WHO).

The PCR methodology
Methodology involves mixing in a closed t

The Test is now available for use across Europe and other countries that accept CE-IVD marking, providing a powerful pandemic and endemic management tool in industries where fast and reliable decentralized testing is crucial. With the launch of its first product, miDiagnostics enters the commercial phase, marking an important milestone in the company’s development.

Ultra-fast and reliable COVID testing on a micro-chip
miDiagnostics’ COVID-19 PCR Test

miDiagnostics, a fast-growing POC diagnostics company backed by Belgian Family Offices, announces today that Nicolas De Clercq, a seasoned financial executive, will join its leadership team as Chief Financial Officer on 1 June 2022.

Nicolas De Clercq brings over 25 years of business experience, joining miDiagnostics from Kinepolis Group, where he has served as Chief Financial Officer since 2012. In recent years, Kinepolis has shown an impressive growth. For his contribution to Kinepol